Levothyroxine and Polystyrene Sulfonate: Interaction Details
AI-assisted, pharmacist-reviewed · Source data updated Aug 8, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Levothyroxine
Polystyrene Sulfonate
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
What happens
Reduced efficacy of levothyroxine and an increased risk of hypothyroidism
Interaction Deep Dive
Coadministration of levothyroxine and ion exchange resins such as polystyrene sulfonate may reduce the efficacy of levothyroxine by binding and delaying or preventing absorption of T4, potentially leading to hypothyroidism1. Avoid concomitant use if possible. If coadministration is required, maximally separate administration 2 and administer levothyroxine at least 4 hours prior to administration of ion exchange resins and monitor TSH levels 341. Administer other oral medications, including prescription and over-the-counter drugs, at least 3 hours before or 3 hours after orally administered cation exchange resins. For patients with gastroparesis or other conditions that delay emptying of food from the stomach into the small intestine, increase this to 6 hours 5.
Why it happens (mechanism)
Binding and delaying or preventing absorption of thyroxine (T4) by a cation exchange resin
Literature reports
1 report — tap to read
a) In a case report, a woman who was coadministered levothyroxine 150 mcg/day after a thyroidectomy and sodium polystyrene sulfonate (SPS) 15 g orally for hyperkalemia developed symptoms of hypothyroidism. Other medications included digoxin, clofibrate, nicotinic acid, calcium carbonate, ferrous sulfate, folic acid, and magnesium trisilicate. Six months after institution of SPS, symptoms of hypothyroidism (lethargy, hoarse voice, facial fullness, weight gain) were evident, free levothyroxine levels were low (3.5 pmol/L), and TSH levels were high (139.5 milliunits/L). Because of speculation that SPS was preventing absorption of levothyroxine, the dose of levothyroxine was increased to 200 mcg/day and was administered 10 hours after SPS. After 6 weeks her symptoms had disappeared, free levothyroxine levels were in the normal range (10 to 25 pmol/L), and TSH levels (5.9 milliunits/L) were only slightly above normal (0.2 to 3 milliunits/L) 6.
Common questions
Can I take Levothyroxine and Polystyrene Sulfonate together?
Reduced efficacy of levothyroxine and an increased risk of hypothyroidism Always confirm with your pharmacist or prescriber before making any change.
How serious is the Levothyroxine and Polystyrene Sulfonate interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "rapid". Effects can appear quickly, often within about 24 hours of combining the drugs.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Levothyroxine or Polystyrene Sulfonate need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (6)
- Product Information: LEVO-T® oral tablets, levothyroxine sodium oral tablets. Neolpharma Inc, Caguas, PR, 2026. DailyMed
- Centanni M, Duntas L, Feldt-Rasmussen U, et al: ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism. Eur Thyroid J 2025; 14(4):e250123. PubMed
- Product Information: TIROSINT(R)-SOL oral solution, levothyroxine sodium oral solution. IBSA Pharma Inc. (per FDA), Parsippany, NJ, 2023. DailyMed
- Product Information: SYNTHROID(R) oral tablets, levothyroxine sodium oral tablets. AbbVie Inc (per FDA), North Chicago, IL, 2024. DailyMed
- US Food & Drug Administration (FDA): FDA Drug Safety Communication: FDA recommends separating dosing of potassium-lowering drug sodium polystyrene sulfonate (Kayexalate) from all other oral drugs. US Food & Drug Administration (FDA). Silver Spring, MD. 2017.
- McLean M, Kirkwood I, Epstein M, et al: Cation-exchange resin and inhibition of intestinal absorption of thyroxine (letter). Lancet 1993; 341:1286. PubMed
Keep reading about Levothyroxine
Keep reading about Polystyrene Sulfonate
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist